Ketoconazole 2% Shampooing: Efficacy and Current Recommendations

Clinical Efficacy

The British Journal of Dermatology states that ketoconazole 2% shampoo is not recommended as the primary treatment for tinea capitis, and should only be used as an adjunct to reduce spore transmission 1
The British Journal of Dermatology recommends that tinea capitis requires oral systemic therapy (griseofulvin or itraconazole) to achieve complete clinical and mycological cure 1

The formulation has minimal systemic absorption when applied to intact skin, according to the American Academy of Dermatology guidelines 2
The most common side effects are mild and transient local irritation, with occasional reports of burning sensation, as noted by the American Academy of Dermatology guidelines 3
In contrast to oral ketoconazole, which carries a risk of hepatotoxicity (1:10,000 to 1:15,000 people exposed), the topical form is much safer for prolonged use, as stated by the Centers for Disease Control and Prevention (CDC) 4
The CDC also notes that topical ketoconazole is safer than oral ketoconazole, which has a higher risk of hepatotoxicity 5

The American Academy of Pediatrics and the Infectious Diseases Society of America recommend against using ketoconazole 2% shampoo as monotherapy for tinea capitis, as it can lead to treatment failure and scarring 1
The CDC advises against confusing topical ketoconazole with systemic infections, as it has no role in treating esophageal candidiasis or invasive fungal infections, where oral ketoconazole is itself considered suboptimal 6